Dr. Cameron B. Harkness
Claim this profileMission Hospital
Area of expertise
Non-Small Cell Lung Cancer
Cameron B. Harkness has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Lung Cancer
Cameron B. Harkness has run 2 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Mission Hospital
Cancer Care Of Western North Carolina
Clinical Trials Cameron B. Harkness is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting
2 awards
Phase 3
28 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting
1 award
Phase 2 & 3
13 criteria
More about Cameron B. Harkness
Clinical Trial Related
10 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Cameron B. Harkness has experience with
- Carboplatin
- Cyclophosphamide
- Doxorubicin Hydrochloride
- Paclitaxel
- Screening Platform
- Biospecimen Collection
Breakdown of trials Cameron B. Harkness has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Cameron B. Harkness specialize in?
Cameron B. Harkness focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Cameron B. Harkness currently recruiting for clinical trials?
Yes, Cameron B. Harkness is currently recruiting for 2 clinical trials in Asheville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Cameron B. Harkness has studied deeply?
Yes, Cameron B. Harkness has studied treatments such as Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride.
What is the best way to schedule an appointment with Cameron B. Harkness?
Apply for one of the trials that Cameron B. Harkness is conducting.
What is the office address of Cameron B. Harkness?
The office of Cameron B. Harkness is located at: Mission Hospital, Asheville, North Carolina 28801 United States. This is the address for their practice at the Mission Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.